NCT03302117

Brief Summary

This is study is to assess pulmonary and systemic effects of exposure to wood smoke. Healthy volunteers will be expose under two different occasion to wood smoke and filtered air under two separated occasions with an interval of 3 weeks in-between. The aim of this study was to determine whether exposure to wood smoke from incomplete combustion would elicit airway inflammation in humans.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 14, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 21, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 4, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2018

Completed
Last Updated

October 4, 2017

Status Verified

September 1, 2017

Enrollment Period

8 months

First QC Date

September 21, 2017

Last Update Submit

October 3, 2017

Conditions

Keywords

Wood smokeBronchoscopy

Outcome Measures

Primary Outcomes (3)

  • Pulmonary inflammation

    Flexible bronchoscopy will done to obtain bronchoalveolar lavage to assess the inflammatory responses by measurement of cell differential counts and cytokines level.

    Bronchoscopy will be done 6 hours after each exposure.

  • Pulmonary cytotoxicity

    Bronchoalveolar lavage will be examined for signs of cytotoxicity by measurement of cell death and apoptosis markers.

    Bronchoscopy will be done 6 hours after each exposure.

  • Inflammatory changes in endobronchial biopsies

    Endobronchial biopsies will be obtained by using flexible bronchoscopy. The biopsies will be stained by using immunohistochemistry method for assessing the inflammatory responses after each exposures

    Bronchoscopy will be done 6 hours after each exposure and the processing of the immunohistochemistry method will start immediately after each bronchoscopy

Secondary Outcomes (2)

  • Systemic inflammatory responses

    Before and 6 hour after each exposure

  • Lung function test

    At baseline, immediately after and 6 hours after each exposure

Interventions

Healthy volunteers will exposed to filtered air alternate with wood smoke generated from incomplete wood smoke combustion to assess the local and systemic effect of theses exposures

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Twenty healthy volunteers (age 20-40, all never smokers) will included. All subjects undergo a physical examination, baseline blood count and renal function assessment, spirometry (FEV1, VC and FEV1/VC) and 12 lead electrocardiogram prior to inclusion. All must be free of airway infection for at least 6 weeks prior to participation. The study was approved by the regional ethical review board and performed in accordance with the declaration of Helsinki. All subjects should give their written informed consent.

You may qualify if:

  • Healthy volunteers
  • Non-smoker
  • Non-allergic

You may not qualify if:

  • Diabetes Mellitus
  • Renal failure
  • Ischemic heart disease
  • History of hematological disease
  • Previous smoking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department for Public Health and Clinical Medicine

Umeå, 90187, Sweden

RECRUITING

Related Publications (6)

  • Friedrich MJ. UNICEF Reports on the Impact of Air Pollution on Children. JAMA. 2017 Jan 17;317(3):246. doi: 10.1001/jama.2016.19034. No abstract available.

    PMID: 28114563BACKGROUND
  • Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax. 2011 Mar;66(3):232-9. doi: 10.1136/thx.2010.147884. Epub 2011 Jan 19.

    PMID: 21248322BACKGROUND
  • Hu G, Zhou Y, Tian J, Yao W, Li J, Li B, Ran P. Risk of COPD from exposure to biomass smoke: a metaanalysis. Chest. 2010 Jul;138(1):20-31. doi: 10.1378/chest.08-2114. Epub 2010 Feb 5.

    PMID: 20139228BACKGROUND
  • Kurmi OP, Semple S, Simkhada P, Smith WC, Ayres JG. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis. Thorax. 2010 Mar;65(3):221-8. doi: 10.1136/thx.2009.124644.

    PMID: 20335290BACKGROUND
  • Unosson J, Blomberg A, Sandstrom T, Muala A, Boman C, Nystrom R, Westerholm R, Mills NL, Newby DE, Langrish JP, Bosson JA. Exposure to wood smoke increases arterial stiffness and decreases heart rate variability in humans. Part Fibre Toxicol. 2013 Jun 6;10:20. doi: 10.1186/1743-8977-10-20.

    PMID: 23742058BACKGROUND
  • Rudell B, Ledin MC, Hammarstrom U, Stjernberg N, Lundback B, Sandstrom T. Effects on symptoms and lung function in humans experimentally exposed to diesel exhaust. Occup Environ Med. 1996 Oct;53(10):658-62. doi: 10.1136/oem.53.10.658.

    PMID: 8943829BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Bronchoalevolar lavage. Endobronchial biopsies. Peripheral blood sampling.

MeSH Terms

Conditions

Pneumonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Ala Muala, MD, PhD

    Department for Public Health and Clinical Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ala Muala, MD, PhD

CONTACT

Thomas Sandström, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 21, 2017

First Posted

October 4, 2017

Study Start

June 14, 2017

Primary Completion

February 8, 2018

Study Completion

February 8, 2018

Last Updated

October 4, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share

Locations